Ali Kaynar is a distinguished molecular cell biologist and bioinformatics expert, specialising in neurodegenerative diseases, particularly glioblastoma (GBM), a formidable brain cancer.

He gained his Bachelor’s degree in Molecular Cell Biology and Genetics from İstanbul Kültür University, Türkiye. Ali then completed a Master’s in Bioinformatics and Systems Biology at Gebze Technical University focusing on computational systems biology. At the core of Ali's research has been his involvement in a TÜBİTAK project, analyzing omic data with genome-scale Metabolic Models (GEMs) to study neurodegenerative diseases. This experience laid the foundation for his current role in the Mardinoglu lab, where he tackles GBM using a computational systems biology approach. Ali is making significant advances in GBM research; a field challenged by high incidence and low survival rates. He utilizes genome-scale metabolic models (GEMs), Regulatory Networks (RNs), and Protein-protein Interaction Networks (PPINs) to create specialized networks for GBM. His work integrates these models to discover new drug targets, early detection biomarkers, and improve patient classification.